Dr. Daniela Katz, MD is a specialist in Internal Medicine and a Medical Oncologist. Dr. Katz was the head of breast and sarcoma services at Assaf Harofeh Medical Center in Israel and today is a senior Oncologist at Shaarei Zedek, Jerusalem. Dr. Katz focuses on wide translational and clinical perspectives of breast cancer and sarcoma and studies specifically personalized targeted immunotherapy aspects in breast cancer and sarcoma.

​

Dr. Katz has graduated medical school, as MD, at the Hadassah Hebrew University Medical School, Jerusalem' Israel in 1996. In 2004 Dr. Katz has become an Internal Medicine specialist and in 2008 she has been certified as a Medical Oncologist. Dr. Katz continued her education focusing on translational research in sarcoma at M.D. Anderson Sarcoma Center as

​

a research fellow. Thereafter, she has established herself as a leading sarcoma specialist. She is an active member of the EORTC sarcoma group and serves as a reviewer of several journals amongst is Annals of Oncology. She has launched two investigator-initiated clinical trials in sarcoma one with ribociclib and the other with nivolumab and ipilimumab.